Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluvoxamine versus desipramine: comparative polysomnographic effects.

D J Kupfer1, J M Perel, B G Pollock

  • 1Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213.

Biological Psychiatry
|January 1, 1991
PubMed
Summary

Fluvoxamine and desipramine, antidepressants for major depression, both suppressed REM sleep. Fluvoxamine had an alerting effect, while desipramine improved sleep continuity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of dorsolateral prefrontal cortex structural measures on neuroplasticity and response to paired-associative stimulation in Alzheimer's dementia.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2024
Same author

Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease.

Molecular psychiatry·2016
Same author

Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study.

Pharmacopsychiatry·2015
Same author

In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.

Molecular psychiatry·2015
Same author

The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.

Molecular psychiatry·2013
Same author

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.

Molecular psychiatry·2011

Area of Science:

  • Neuroscience
  • Psychiatry
  • Sleep Medicine

Background:

  • Major depressive disorder (MDD) affects sleep architecture.
  • Antidepressant medications can alter sleep patterns, including REM sleep.
  • Understanding these effects is crucial for treatment optimization.

Purpose of the Study:

  • To compare the effects of fluvoxamine and desipramine on sleep measures in patients with major depression.
  • To investigate the relationship between sleep alterations and antidepressant efficacy.

Main Methods:

  • A randomized, double-blind trial involving 35 inpatients with unipolar major depression.
  • Electroencephalogram (EEG) sleep measures were recorded over a 4-week treatment period.
  • Participants received either fluvoxamine or desipramine.

Related Experiment Videos

Main Results:

  • Fluvoxamine demonstrated immediate REM sleep suppression and an alerting effect on sleep continuity.
  • Desipramine administration was associated with REM sleep suppression and improved sleep continuity.
  • The alerting effect of fluvoxamine may be linked to persistent REM sleep suppression, but not necessarily lack of clinical efficacy.

Conclusions:

  • Both fluvoxamine and desipramine impact REM sleep in depressed patients.
  • Fluvoxamine's alerting effect is distinct from its clinical efficacy and may relate to REM sleep changes.
  • Further research is needed to confirm the serotonin specificity for REM sleep suppression.